Clinical Trials
17 trialsNCT06018883 2025-08-07
PTCA199-3
Fudan University
Phase 3 Active not recruiting
NCT05407987 2025-04-25
FORGE II
AHS Cancer Control Alberta
Phase 3 Recruiting
NCT03837171 2024-06-25
TRANSPORT
Assistance Publique - Hôpitaux de Paris
Phase 3 Completed
NCT00310232 2024-04-02
Epoetin Alfa in Advanced Non-Small Cell Lung Cancer (EPO-CAN-20)
Ontario Clinical Oncology Group (OCOG)
Phase 3 Terminated
NCT04910594 2021-08-11
Clinical Study the Efficacy and Safety of Rh-EPO in the Treatment of Anemia in Lymphoma
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 3 Unknown
NCT00303784 2020-11-27
PATCH
University College, London
Phase 3 Unknown
NCT00070382 2020-08-03
Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer
Jonsson Comprehensive Cancer Center
Phase 3 Completed
NCT00281892 2018-05-11
Fludarabine and Darbepoetin Alfa in Treating Older Patients With Chronic Lymphocytic Leukemia
German CLL Study Group
Phase 3 Completed
NCT00131716 2017-01-12
Prevention of Severe Anaemia in Gambian Children
London School of Hygiene and Tropical Medicine
Phase 3 Completed
NCT00058331 2016-07-18
Epoetin Alfa in Treating Anemia in Patients With Solid Tumors
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT00003600 2016-07-13
Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT00003341 2013-07-03
Epoetin Alfa in Treating Anemia in Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma and Anemia Caused By Chemotherapy
Memorial Sloan Kettering Cancer Center
Phase 3 Completed
NCT01648946 2012-11-06
TRICCOP
Instituto do Cancer do Estado de São Paulo
Phase 3 Unknown
NCT00661999 2011-05-17
Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer
Mayo Clinic
Phase 3 Completed
NCT00921635 2009-06-19
HOSTT
Tri-Service General Hospital
Phase 3 Suspended
NCT00145652 2007-07-30
Adjuvant I.V. Iron Therapy During Erythropoetin Treatment of Anemic Patients With Lymphoproliferative Disorders.
Sundsvall Hospital
Phase 3 Completed
NCT00189371 2005-09-19
Reinduction Chemotherapy Containing Carboplatin and Paclitaxel With or Without Epoetin Alpha in Recurrent Platinum Sensitive Ovarian Cancer, Cancer of the Fallopian Tube or Peritoneum
AGO Study Group
Phase 3 Terminated